Osama N, Amer NN, Mohamed AA, Salah M, Ezz Al Arab MR, El-Awady RR. Comparison between miR-199b-5p and AFP in the diagnosis of hepatitis C-associated hepatocellular carcinoma. Azhar International J Pharmaceutical Med Sci. 2025;5(1):99–108.

Google Scholar 

Singh SP, Madke T, Chand P. Global epidemiology of hepatocellular carcinoma. J Clin Exp Hepatol. 2025;15(2):102446.

Article  CAS  PubMed  Google Scholar 

Salman MA, Omar HS, Mikhail HM, Tourky M, El‐ghobary M, Elkassar H, et al. Sarcopenia increases 1‐year mortality after surgical resection of hepatocellular carcinoma. ANZ J Surg. 2020;90(5):781–5.

Article  PubMed  Google Scholar 

Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63.

PubMed  Google Scholar 

Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6.

Article  PubMed  Google Scholar 

Blach S, Terrault NA, Tacke F, Gamkrelidze I, Craxi A, Tanaka J, et al. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study. Lancet Gastroenterol Hepatol. 2022;7(5):396–415.

Article  Google Scholar 

Ioannou GN, Green PK, Berry K. HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma. J Hepatol. 2020;72(1):25–36.

Article  Google Scholar 

Fekry N, Abd Elmaqsoud ELS, Al Kasaby Z, Abu-ElFotuh K. Hepatocellular carcinoma after treatment of cirrhotic Hepatitis C Virus patients with direct acting antiviral treatment. Azhar International J Pharmaceutical Med Sci. 2025;5(1):17–26.

Google Scholar 

El-Serag HB, Kanwal F, Feng Z. Risk factors for cirrhosis in contemporary hepatology practices - findings from the Texas Hepatocellular Carcinoma Consortium cohort. Gastroenterology. 2022;163(3):666–78.

Google Scholar 

Albhaisi SAM, Bajaj JS, Sanyal AJ. Role of gut microbiota in liver disease. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2020. https://doi.org/10.1152/ajpgi.00118.2019.

Article  PubMed  Google Scholar 

Tripathi A, Debelius J, Brenner DA. The gut-liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol. 2021;18(6):397–411.

Google Scholar 

Csader S, Chen X, Leung H, Männistö V, Pentikäinen H, Tauriainen M-M, et al. Schwab U. Panagiotou G: Gut ecol net reveal associations between bacteria, exercise, clinical profile in non-alcoholic fatty liver disease patients. 2023;8(5):e00224-e1223.

Google Scholar 

Sammallahti H, Rezasoltani S, Pekkala S, Kokkola A, Asadzadeh Agdaei H, Azizmohammad Looha M, et al. Fecal profiling reveals a common microbial signature for pancreatic cancer in Finnish and Iranian cohorts. Gut Pathog. 2025;17(1):24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aly AM, Adel A, El-Gendy AO, Essam TM, Aziz RK. Gut microbiome alterations in patients with stage 4 hepatitis C. Gut pathogens. 2016;8:1–12.

Article  Google Scholar 

Bajaj JS, Kakiyama G, Zhao D, Fagan A, Daita K, Gavis EA, et al. Continued alcohol misuse in human cirrhosis is associated with an impaired gut-liver axis. Alcohol Clin Exp Res. 2019;43(1):123–32.

Google Scholar 

Hammerich L, Tacke F. Hepatic inflammatory responses in liver fibrosis. Nat Rev Gastroenterol Hepatol. 2023;20(10):633–46.

Article  CAS  PubMed  Google Scholar 

Ponziani FR, Bhoori S, Castelli C, Putignani L, Rivoltini L, Del Chierico F, et al. Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease. Hepatology. 2019;69(1):107–20.

Article  CAS  PubMed  Google Scholar 

Shen S, Khatiwada S, Behary J, Kim R, Zekry A. Modulation of the gut microbiome to improve clinical outcomes in hepatocellular carcinoma. Cancers (Basel). 2022;14(9):2099.

Article  CAS  PubMed  Google Scholar 

Kanwal F, Kramer J, Asch SM. Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents. Gastroenterology. 2021;161(3):995–1005.

Google Scholar 

Lapidot Y, Amir A, Nosenko R, Uzan-Yulzari A, Veitsman E, Cohen-Ezra O, et al. Alterations in the gut microbiome in the progression of cirrhosis to hepatocellular carcinoma. mSystems. 2020;5(3):10–1128.

Article  Google Scholar 

Brozzetti S, Tancredi M, Bini S, De Lucia C, Antimi J, D’Alterio C, et al. Hcc in the era of direct-acting antiviral agents (DAAs): surgical and other curative or palliative strategies in the elderly. Cancers. 2021;13(12):3025.

Article  PubMed  PubMed Central  Google Scholar 

El-Mowafy M, El-Mesery M, El-Kadem AH. Changes in gut microbiome composition following direct-acting antiviral therapy in hepatitis C patients. World J Gastroenterol. 2023;29(8):1345–60.

Google Scholar 

Abosheaishaa H, Abdelmalek A, Omar A, Islam M, Samah M, Mohammed Y, Ahmed S, A. BA, Ahmed S, S. NM et al 2024: The Egyptian journey from having the highest prevalence of hepatitis C virus to being the first to achieve “gold tier” in conquering the disease. Baylor University Medical Center Proceedings, 37(5):877–883.

Caussy C, Hsu C, Lo M-T, Liu A, Bettencourt R, Ajmera VH, et al. Link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD. Hepatology. 2020;71(1):22–35.

Google Scholar 

Kelly BJ, Gross R, Bittinger K, Sherrill-Mix S, Lewis JD, Collman RG, et al. Power and sample-size estimation for microbiome studies using pairwise distances and PERMANOVA. Bioinformatics. 2015;31(15):2461–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

EASL. EASL recommendations on treatment of hepatitis C 2016. J Hepatol. 2017;66(1):153–94.

Article  Google Scholar 

Abdel-Moneim A, Aboud A, Abdel-Gabaar M, Zanaty MI, Ramadan M. Efficacy and safety of sofosbuvir plus daclatasvir with or without ribavirin: large real-life results of patients with chronic hepatitis C genotype 4. Hepatol Int. 2018;12(4):348–55.

Article  PubMed  Google Scholar 

World Medical A. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–4.

Article  Google Scholar 

El-Akel W, El-Sayed MH, El Kassas M. National treatment program of hepatitis C in Egypt: hepatitis C virus model of care. J Viral Hepat. 2018;25:262–7.

Google Scholar 

Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68(2):723–50.

Article  PubMed  Google Scholar 

Abduljabbar AH, Wazzan MA. Diagnostic performance of US LI-RADS in hepatocellular carcinoma surveillance. Egypt J Radiol Nucl Med. 2023;54(1):134.

Article  Google Scholar 

Omran D, Alboraie M, Zayed RA. GALAD score for early detection of hepatocellular carcinoma in Egyptian patients with chronic HCV. Clin Exp Hepatol. 2022;8:12–8.

Google Scholar 

Ramadan M, Solyman S, Yones M, Abdallah Y, Halaby H, Hanora A. Skin microbiome differences in atopic dermatitis and healthy controls in Egyptian children and adults, and association with serum immunoglobulin E. OMICS. 2019;23(5):247–60.

Article  CAS  PubMed  Google Scholar 

Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13(7):581–3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2013;41(D1):D590–6.

Article  CAS  PubMed  Google Scholar 

Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007;73(16):5261–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol. 1995;57(1):289–300.

Article  Google Scholar 

Anderson MJ: Permutational Multivariate Analysis of Variance (PERMANOVA). Wiley StatsRef: Statistics Reference Online 2017:1–15.

Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.

Article  PubMed  PubMed Central  Google Scholar 

Mallick H, Rahnavard A, McIver LJ, Ma S, Zhang Y, Nguyen LH, et al. Multivariable association discovery in population-scale meta-omics studies. PLoS Comput Biol. 2021;17(11):e1009442.

Article  CAS  PubMed